|
Keynote Forum |
|
|
Day 1: Morning, May 11, 2022 |
|
|
Moderator |
Call for Moderator |
|
Time |
Speeches and Speakers |
|
09:00-09:05 |
Chair's Introduction |
|
09:05-09:30 |
Title: TBD Dr. H. Michael Shepard, President and CEO, Enosi Life Sciences, USA 2019 Lasker Awards |
|
09:30-09:55 |
Title: How Spearheading Cell & Gene Therapy Changes Our Innovation Model in Pharma Dr. Wolfram Carius, Executive Vice President of Cell and Gene Therapy, Pharmaceuticals Division, Bayer Pharmaceuticals, Germany |
|
09:55-10:20 |
Title: Cell-penetrating Peptides and Drug Delivery Dr. Ulo Langel, Professor, Stockholm University, Sweden Member of the Academia Europaea; Foreign Member of Estonian Academy of Science |
|
10:20-10:45 |
Title: Genomes, Structural Biology and Drug Discovery: Combating the Impacts of Mutations in Genetic Disease and Antibiotic Resistance Dr. Tom Blundell, Professor, Department of Biochemistry, University of Cambridge, UK Member of Academia Europaea; Fellow of the Royal Society; Fellow of Academy of Medical Sciences |
|
10:45-11:10 |
Speech Opportunity Available |
|
11:10-11:35 |
Speech Opportunity Available |
|
Session 211: Pharmacogenetics, Pharmacogenomics and Precision Medicine |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Dr. Chuang Kee Ong, Associate Director, Centre of Genomics Research, Precision Medicine and Genomics, AstraZeneca UK Limited, UK |
|
Co-Chair |
Dr. Fan-Gang Tseng, Distinguished Professor and Vice President for Research and Development, National Tsing Hua University Taiwan,Taiwan (China) |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair's Introduction |
|
13:35-13:55 |
Keynote Speech Title: Predictive, Preventive and Personalized Medicine (PPPM) as a Strategic Avenue and Global Tool for Advancing T1D-related Care Dr. Sergey Suchkov, Professor, Department of Clinical Allergology & Immunology, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Russia |
|
13:55-14:15 |
Title: Beyond Cancer and Rare Disease: Extending Precision Medicine into Chronic Diseases Dr. Steve Gardner, CEO, PrecisionLife Ltd, UK |
|
14:15-14:35 |
Title: AstraZeneca’s 2 Millions Genomes Initiative and the relevance of FAIR Data Principles in Pharmaceutical R&D Dr. Chuang Kee Ong, Associate Director, Centre of Genomics Research, Precision Medicine and Genomics, AstraZeneca UK Limited, UK |
|
14:35-14:55 |
Title: TBD Dr. Michelle Chen, Vice President, Head of Corporate Development, WuXi Biologics, USA |
|
14:55-15:15 |
Title: Automatic SACA System for Single Circulating Tumor Cells/Microembolis (CTCs/CTMs) Rapid Diagnosis/Prognosis Dr. Fan-Gang Tseng, Distinguished Professor, National Tsing Hua University Taiwan,Taiwan (China) |
|
15:20-15:30 |
Coffee Break |
|
15:30-15:50 |
Title: TBD Dr. Concetta Ambrosino, Associate Professor, UNIVERSITÀ DEGLI STUDI DEL SANNIO, Italy |
|
15:50-16:10 |
Title: Methods of Screening Diagnostics of Human Health Using the IT-technologies Dr. Aizman Roman, Professor, Novosibirsk State Pedagogical University, Russia |
|
16:10-16:30 |
Title: Aberrant RNA Metabolism in Amyotrophic Lateral Sclerosis (ALS) Caused by Mutations in C9ORF72 Gene Dr. Hitomi Tsuiji, Senior Lecturer, Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Japan |
|
16:30-16:50 |
Title: The Precision Medicine of Infertility Dr. Chiungfang Peng, President & CEO, FUGA Biotechnology Co, Ltd., Taiwan (China) |
|
16:50-17:10 |
Speech Opportunity Available |
|
Session 221: Innovative Drug Discovery Technology |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Dr. Richard Denk, Senior Consultant, Aseptic Processing & Containment, SKAN AG, Switzerland |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair's Introduction |
|
13:35-13:55 |
Title: New Insights into the Use of Hydroxypropyl Cellulose for Drug Solubility Enhancement |
|
13:55-14:15 |
Title: GMP and Occupational Safety for the Commercial Manufacturing of Gene and Cell Therapies Dr. Richard Denk, Senior Consultant, Aseptic Processing & Containment, SKAN AG, Switzerland |
|
14:15-14:35 |
Title: Mimotope a New Method to Develop Vaccines Stable at 4°C Dr. Erwann P. Loret, Aix Marseille University, France |
|
14:35-14:55 |
Speech Opportunity Available |
| 14:55-15:15 |
Title: Cell Culture Based Biologics Production in Serum/Animal Protein-free Conditions |
|
15:15-15:30 |
Coffee Break |
|
Session 311: Cancer Drug Targets |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Dr. Anna Juncker-Jensen, Principal Scientist, NeoGenomics Laboratories, Inc., USA |
|
Co-Chair |
Dr. Xiaoyan Jiang, Professor, University of British Columbia, Canada |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair's Introduction |
|
13:35-13:55 |
Title: Oxidized Macrophage Migration Inhibitory Factor (oxMIF) – an Unrecognized Target for Cancer Therapeutics Dr. Randolf Kerschbaumer, Managing Director & CEO, OncoOne Research & Development GmbH, Austria |
|
13:55-14:15 |
Title: TBD Dr. Anna Juncker-Jensen, Principal Scientist, NeoGenomics Laboratories, Inc., USA |
| 14:15-14:35 |
Title: Drug Targeting Approaches against KRAS Surrogate Targets Dr. Daniel Abankwa, Professor, Department of Life Sciences and Medicine, University of Luxembourg, Luxembourg |
|
14:35-14:55 |
Title: TBD Dr. Mohan Natarajan, Professor, Department of Pathology & Integrative Physiology School of Medicine, University of Texas Health Sciences Center, USA |
|
14:55-15:15 |
Title: TBD Dr. Xiaoyan Jiang, Professor, University of British Columbia, Canada |
|
15:15-15:30 |
Coffee Break |
| 15:30-15:50 |
Title: The Construction of Structurally Diverse Covalent Inhibitor Library and Their Application in Drug Discovery for Rare Cancer Dr. Shunying Liu, Professor, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Chemical Engineering, East China Normal University, China |
|
15:50-16:10 |
Title: Therapy-driven Molecular Evolution and Its Implications for Predicting Drug Response in Glioblastoma Dr. Ella L Kim, Department of Neurosurgery, Johannes Gutenberg University Medical Centre, Germany |
|
16:10-16:30 |
Speech Opportunity Available |
|
16:30-16:50 |
Title: Neuroendocrine Differentiation in Prostate Cancer Dr. Luca Puccetti, Division of Urology, San Lazzaro Hospital, Italy |
|
16:50-17:10 |
Title: The E3 Ubiquitin-ligase Hakai as a Novel Therapeutic Strategy against Cancer Dr. Angelica Figueroa, Research Group Leader, Institute for Biomedical Research of A Coruna (INIBIC), Spain |
|
Session 321: Open Innovation in Drug Discovery |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Dr. Wolfgang Fecke, Director General, EU-OPENSCREEN, Germany |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair's Introduction |
|
13:35-13:55 |
Title: How LEO Pharma Advances Innovation in Medical Dermatology through Partnerships around the World Dr. Hitoshi Shiota, Scientist, LEO Science & Tech Hub Tokyo, Japan |
|
13:55-14:15 |
Title: Access to the European Infrastructure for Chemical Biology EU-OPENSCREEN Dr. Wolfgang Fecke, Director General, EU-OPENSCREEN, Germany |
|
14:15-14:35 |
Speech Opportunity Available |
|
14:35-14:55 |
Title: The National Institute of Health Research Nottingham Biomedical Research Centre as a Framework for Partnership to Drive Drug Discovery Dr. Maria Koufali, Managing Director, Research and Innovation, Nottingham University Hospitals NHS Trust, UK |
|
14:55-15:15 |
Title: Ketamine/Propofol Admixture (“KETOFOL”) for Sedation: The Real Deal or Not? Dr. Nathan J Smischney, Associate Professor, Department of Anesthesiology, Mayo Clinic, USA |
|
15:15-15:30 |
Coffee Break |
|
Session 411: Cancers/Tumors |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Dr. Yan Leyfman, Professor, Penn State College of Medicine, USA |
| Co-Chair |
Dr. Kiyoshi Eshima, President, Department of Oncology Research and Development, Delta-Fly Pharm, Inc, Japan |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair's Introduction |
|
13:35-13:55 |
Speech Opportunity Available |
|
13:55-14:15 |
Speech Opportunity Available |
|
14:15-14:35 |
Title: Emerging Approaches and Techniques in the Management of Aneurysmal Bone Cysts Dr. Gennady N Machak, Priorov Central Institute for Traumatology and Orthopedics, Russia |
| 14:35-14:55 |
Title: Thermal IR Imaging of Tumors and Inner Cancerous Anomalies Injected in Mice for Temperature Contrast Assessment – Experimental Results Dr. Nathan Blaunstein, Professor-Emeritus, Ben Gurion University of the Negev, Israel |
| 14:55-15:15 |
Title: Primary Endpoints in Interventional Oncology Clinical Trials: towards a Consensus Paper Dr. Lucio Fumi, CEO, Wyfold Medical, UK |
|
15:15-15:35 |
Title: Robotic Surgery in Oncologic Urology Dr. Anton Ponholzer, Guest Professor, Medical University of Vienna, Austria |
|
15:35-15:50 |
Coffee Break |
| 15:50-16:10 |
Title: Module Technology for Cancer Chemotherapy Dr. Kiyoshi Eshima, President, Department of Oncology Research and Development, Delta-Fly Pharm, Inc, Japan |
| 16:10-16:30 |
Title: Off Label Medication in Obstetrics Dr. Ioana-Claudia Lakovschek, Department of Obstetrics and Gynecology, Medical University of Graz, Austria |
| 16:30-16:50 |
Title: Controversies, Consensus and Collaboration in the Use of I-131 Therapy in Differentiated Thyroid Cancer Dr. Ciprian Draganescu, Head of Nuclear Medicine Department, University Hospital of Martinique, Martinique |
| 16:50-17:10 |
Title: Colorectal Cancer Stem Cell Vaccine with High Expression of MUC1 Serves as a Novel Prophylactic Vaccine for Colorectal Cancer Dr. Jun Dou, Reseacher, Southeast University, China |
|
17:10-17:30 |
Title: Can Physical Activity Enhance Breast Cancer Suvivors' Sleep Dr. Hongchang Yang, Hohai University, China |
|
Session 421: Recent Advances in Immunotherapy |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Dr. Milosevic Slavoljub, Vice President, Medigene AG, Germany |
| Co-Chair |
Dr. Melita Irving, Group Leader, Department of Oncology Ludwig Institute for Cancer Research, University of Lausanne, Switzerland |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: Th1-epitope Peptide is Critical for Potentiating Therapeutic Efficacy of Cancer in H/K-HELP Vaccine Therapy and DC-based Vaccine Cell Therapy Dr. Takashi Nishimura, Director, NPO Immuno support Center, Japan |
|
14:00-14:25 |
Title: Identifying Functional Neo-antigens by HTS Dr. Milosevic Slavoljub, Vice President, Medigene AG, Germany |
|
14:25-14:50 |
Title: Expression Data Integration: Advancing Immuno-oncology Target Discovery Dr. Frank Staubli, Nebion AG, Switzerland |
|
14:50-15:15 |
Title: Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma Dr. Mike Eccles, Professor, New Zealand Institute for Cancer Research Trust, New Zealand |
|
15:15-15:30 |
Coffee Break |
|
15:30-15:55 |
Title: Immunotherapy for Gastric Cancer by Targeting a Specific Chemokine Dr. Wei-Qiang Gao, "KC Wong" Endowed Chair Professor, Dean of Med-X Research Institute, Director of Renji Hospital Stem Cell Research Center, Shanghai Jiao Tong University, China |
|
15:55-16:20 |
Title: Next Generation T-cell Engineering Strategies Against Solid Tumors |
|
16:20-16:45 |
Speech Opportunity Available |
|
16:45-17:10 |
Title: How can Drug Delivery Approaches Enhance Immunotherapy? Dr. Sifei Han, NHMRC Early Career Fellow, Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Australia |
|
Session 431: Natural Product Discovery |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Dr. Dulcie A Mulholland, Professor, Department of Chemistry, University of Surrey, UK |
| Co-Chair | Dr. Chen Situ, Lecturer, School of Biological Sciences, Queen’s University Belfast, UK |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: Monoterpens as New Biologics and Geroprotectors Dr. Patrizia A. d'Alessio, CEO, AISA Therapeutics & Head of ISOAD France, France |
|
14:00-14:25 |
Title: The Use of Homoisoflavonoids in the Treatment of Retinopathy Dr. Dulcie A Mulholland, Professor, Department of Chemistry, University of Surrey, UK |
|
14:25-14:50 |
Title: The Benefit of Plant Natural Compounds Affecting the Arachidonic Acid Pathway Dr. Lenka Langhansova, Associate Researcher, The Institute of Experimental Botany, The Czech Academy of Sciences (CAS), Czech Republic |
|
14:50-15:15 |
Title: Poly(Sugar Acids): Novel Acidic Polysaccharide Poly[3-(3,4-Dihydroxyphenyl)Glyceric Acid] from Medicinal Plants of Boraginaceae Family its Synthetic Analogues and Their Anticancer Efficaccy Dr. Vakhtang Barbakadze, Head of Department of Plant Biopolymers, Kutateladze Institute of Pharmacochemistry, Tbilisi State Medical University, Georgia |
|
15:15-15:30 |
Coffee Break |
| 15:30-15:55 |
Title: How can Commercially Available Enzymes Contribute to the Discovery of New Nutraceuticals? Dr. Lutz Fischer, Professor, Department of Biotechnology and Enzyme Science, Institute of Food Science and Biotechnology, University of Hohenheim, Germany |
| 15:55-16:20 |
Speech Opportunity Available |
| 16:20-16:45 |
Title: Biological Activity and Pharmacological Properties of Polynesian Calophyllum Inophyllum Oil Extracts Dr. Phila Raharivelomanana, Professor, University of French Polyneisa, FRENCH POLYNESIA |
| 16:45-17:10 |
Title: Antibacterial Multitarget Properties of Medicinal Plants Dr. Chen Situ, Lecturer, School of Biological Sciences, Queen’s University Belfast, UK |
|
Stream 5: Young Scientist Forum |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: Image-based Powder Flow Characterization: An Additional Tool for Process Optimization in the Pharmaceutical Industry Mr. David Blanco, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Finland |
|
14:00-14:25 |
Speech Opportunity Available |
|
14:25-14:50 |
Title: Cancer Risk after Cardiac Catheterization in Childhood Mr. Kossi D Abalo, Laboratory of Epidemiology, Institute for Radiological Protection and Nuclear Safety, France |
|
14:50-15:15 |
Title: Accelerating Recruitment of Alzheimer's Disease Clinical Trials through Open Access Memory Testing Mr. Daniel Wojcik, Medical University of Lodz, Poland |
|
15:15-15:30 |
Coffee Break |
© 2003-2022 All rights reserved by BITeomics |